424 related articles for article (PubMed ID: 20132860)
1. Overview: Japanese encephalitis.
Misra UK; Kalita J
Prog Neurobiol; 2010 Jun; 91(2):108-20. PubMed ID: 20132860
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological situation of Japanese encephalitis in Nepal.
Bista MB; Shrestha JM
JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
[TBL] [Abstract][Full Text] [Related]
3. Japanese encephalitis for a reference to international travelers.
Oya A; Kurane I
J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
[TBL] [Abstract][Full Text] [Related]
4. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.
Gajanana A; Thenmozhi V; Samuel PP; Reuben R
Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596
[TBL] [Abstract][Full Text] [Related]
5. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
6. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis.
Kalita J; Misra UK; Pandey S; Dhole TN
Arch Neurol; 2003 Dec; 60(12):1760-4. PubMed ID: 14676053
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA.
Shukla J; Bhargava R; Dash PK; Parida M; Tripathi N; Rao PV
J Virol Methods; 2009 Jun; 158(1-2):165-70. PubMed ID: 19428586
[TBL] [Abstract][Full Text] [Related]
8. Japanese encephalitis in two children--United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(9):276-8. PubMed ID: 21389931
[TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis vaccine: need of the hour in endemic states of India.
Verma R
Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
[TBL] [Abstract][Full Text] [Related]
11. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
[TBL] [Abstract][Full Text] [Related]
12. IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection.
Jones T
Curr Opin Mol Ther; 2009 Feb; 11(1):90-6. PubMed ID: 19169964
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.
Arai S; Matsunaga Y; Takasaki T; Tanaka-Taya K; Taniguchi K; Okabe N; Kurane I;
Jpn J Infect Dis; 2008 Sep; 61(5):333-8. PubMed ID: 18806337
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis vaccines: moving away from the mouse brain.
Zanin MP; Webster DE; Martin JL; Wesselingh SL
Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
[TBL] [Abstract][Full Text] [Related]
15. The first report on human cases serologically diagnosed as Japanese encephalitis in Indonesia.
Yoshida M; Igarashi A; Suwendra P; Inada K; Maha MS; Kari K; Suda H; Antonio MT; Arhana BN; Takikawa Y; Maesawa S; Yoshida H; Chiba M
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):698-706. PubMed ID: 10928363
[TBL] [Abstract][Full Text] [Related]
16. Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature.
Chung CC; Lee SS; Chen YS; Tsai HC; Wann SR; Kao CH; Liu YC
Infection; 2007 Feb; 35(1):30-2. PubMed ID: 17297587
[TBL] [Abstract][Full Text] [Related]
17. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
18. Recurrent outbreaks of Japanese encephalitis in Nagaland (1985-1989)--a seroepidemiological study.
Mukherjee KK; Chakravarti SK; Mukherjee MK; De PN; Chatterjee S; Chatterjee P; Chakraborty MS
J Commun Dis; 1991 Mar; 23(1):11-7. PubMed ID: 1655865
[TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis: development of new candidate vaccines.
Bharati K; Vrati S
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
